Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus

ClinicalTrials.gov ID: NCT04882878

Public ClinicalTrials.gov record NCT04882878. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 12:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus

Study identification

NCT ID
NCT04882878
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
228 participants

Conditions and interventions

Interventions

  • Placebo Other
  • Nipocalimab Drug
  • Standard-of-care treatment Drug

Other · Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 19, 2021
Primary completion
Apr 29, 2024
Completion
Dec 25, 2024
Last update posted
Dec 7, 2025

2021 – 2024

United States locations

U.S. sites
21
U.S. states
9
U.S. cities
21
Facility City State ZIP Site status
Valerius Medical Group & Research Center Los Alamitos California 90720
Desert Medical Advances Rancho Mirage California 92270
Wolverine Clinical Trials Santa Ana California 92705
Millennium Clinical Trials LLC Westlake Village California 91361
Bay Area Arthritis and Osteoporosis Brandon Florida 33511
GNP Research Cooper City Florida 33024
South Coast Research Center Miami Florida 33136
Advanced Clinical Research of Orlando Ocoee Florida 34761
Omega Research Consultants Orlando Florida 32808
Millennium Research Ormond Beach Florida 32174
North Georgia Rheumatology, PC Lawrenceville Georgia 30046
Atlanta Research Center for Rheumatology Marietta Georgia 30060
West County Rheumatology St Louis Missouri 63131
DJL Clinical Research, PLLC Charlotte North Carolina 28210
Paramount Medical Research & Consulting Middleburg Heights Ohio 44130
Dr. Ramesh Gupta Memphis Tennessee 38119
Arthritis and Rheumatology Research Institute Allen Texas 75013
Precision Comprehensive Clinical Research Solutions Colleyville Texas 76034
Southwest Rheumatology Research LLC Mesquite Texas 75150
Epic Medical Research Red Oak Texas 75154
Rheumatology and Pulmonary Clinic Beckley West Virginia 25801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 65 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04882878, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 7, 2025 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04882878 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →